Private equity firm General Atlantic has agreed to invest $200 million in Nashville, Tenn.-based OneOncology, a startup that aims to manage independent cancer treatment clinics, according to The Wall Street Journal.
The company's founders and first customers are three cancer treatment practices in New York and Tennessee. The $200 million investment makes General Atlantic the majority owner of the startup, according to the report.
"With the launch of OneOncology, we hope to transform the future of cancer care," Tracy Bahl, OneOncology's president and CEO, said in a press release. "Cancer is increasingly being treated like a chronic condition rather than a terminal diagnosis. Working together with world-class oncologists, we will drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer."
More articles on healthcare finance:
12 hospitals with strong finances
Cash-strapped California hospital to close ER Sept. 16
MU Health Care's annual revenue hits $1B for first time